SHSE:603014's FCF Margin % is ranked better than 84.82% of 817
companies
in the Medical Devices & Instruments industry
Industry Median: -0.34
vs SHSE:603014: 15.07
Shandong Weigao Blood Purification Products Co FCF Margin % Related Terms
Shandong Weigao Blood Purification Products Co FCF Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shandong Weigao Blood Purification Products Co FCF Margin % Chart
Shandong Weigao Blood Purification Products Co Annual Data
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shandong Weigao Blood Purification Products Co FCF Margin % vs Medical Devices & Instruments Industry
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shandong Weigao Blood Purification Products Co (SHSE:603014) has a FCF Margin % of -3.18% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Shandong Weigao Blood Purification Products Co and its competitors. Over the past decade, Shandong Weigao Blood Purification Products Co's FCF Margin % has ranged from 1.57 to 16.82. According to the industry distribution chart, Shandong Weigao Blood Purification Products Co ranks #124 out of 817 companies in the Medical Devices & Instruments industry, placing it in the top 15.2%.
Is Shandong Weigao Blood Purification Products Co's FCF Margin % too high?
Shandong Weigao Blood Purification Products Co's current FCF Margin % is -3.18%. Over the past 10 years, this metric has ranged from a low of 1.57 to a high of 16.82. Based on the distribution chart, Shandong Weigao Blood Purification Products Co ranks #124 out of 817 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Shandong Weigao Blood Purification Products Co has a GF Score™ of 38/100, reflecting its overall financial health beyond just this single metric.
How does Shandong Weigao Blood Purification Products Co's FCF Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Shandong Weigao Blood Purification Products Co ranks #124 out of 817 companies for FCF Margin %. This places Shandong Weigao Blood Purification Products Co in the top 15% of its industry — outperforming the majority of peers. Historically, Shandong Weigao Blood Purification Products Co's own FCF Margin % has ranged from 1.57 to 16.82 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Shandong Weigao Blood Purification Products Co and its competitors. Shandong Weigao Blood Purification Products Co's current FCF Margin % is -3.18%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shandong Weigao Blood Purification Products Co stock overvalued right now?
Shandong Weigao Blood Purification Products Co (SHSE:603014) has a current FCF Margin % of -3.18%. The current FCF Margin % is -3.18%. Shandong Weigao Blood Purification Products Co's overall GF Score™ is 38/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Shandong Weigao Blood Purification Products Co (SHSE:603014), the current FCF Margin % is -3.18% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Shandong Weigao Blood Purification Products Co Business Description
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603014 has been successfully added to your 
